Le Lézard
Classified in: Health
Subjects: SVY, MAT

Exploring the power of ibogaine treatment with The Avante Institute


NASSAU, Bahamas, March 21, 2018 /PRNewswire/ --  Ibogaine treatment is an intensive plant-based medicinal therapy, employing the concept of holistic detoxification, and entirely different from treatment methods typically used in western medicine.

Ibogaine has been used for generations by a number of West African cultures?including the Babongo, Bwiti, Mitsogo, and Fang peoples of Gabon and Cameroon?in healing ceremonies, rite of passage and religious rituals.

However, unlike traditional addiction and detox therapies, where patients invariably suffer from withdrawal and constant cravings for the addictive substance which they are trying to quit, ibogaine treatment eliminates all post-acute withdrawal symptoms, alleviates cravings, and allows the individual to undertake recovery in a stable, unwavering, and formidable manner.

Ibogaine treatment also provides the body with a full detox by resetting the brain's neurological addiction receptors and returning it to a pre-addiction state.

In the late 1960s, American scientific researcher Howard Lotsof, having himself become addicted to heroin, accidentally discovered?through his own recreational use?that ibogaine had the power to eradicate his dependence on opiates.

After years of persuasion by Lotsof, fellow researchers collectively investigated the medicinal properties of ibogaine and confirmed that it did indeed prove highly effective in reducing drug dependency. Further studies went on to show that a detoxification program using ibogaine was considerably more effective and successful at achieving long-term sobriety than traditional detox protocols which were already in place.

While, as of 2018, ibogaine is not currently approved for medical use in the United States, it is used as an alternative form of therapy for drug addiction in many other countries. Ibogaine treatment is available in countries such as Canada, Brazil, Germany, and Norway, among others.

One other such country, The Bahamas, is home to The Avante Institute. Patients undergo a comprehensive pre-screening process prior to receiving ibogaine treatment. This includes complex toxicological analysis of the blood and urine, an electrocardiogram, and a psychological evaluation by the Institutes licensed psychiatrist.

Throughout ibogaine treatment and drug detoxification at The Avante Institute, patients are closely monitored by a team of highly-trained clinical staff.

To find out more about ibogaine treatment at The Avante Institute, please visit https://avanteinstitute.com/ or call the Institute directly @ (242) 804.4402 or (844) 4.AVANTE.

SOURCE The Avante Institute


These press releases may also interest you

at 04:00
Today Benchling announced that Zealand Pharma A/S, ("Zealand") a biotechnology company focused on the discovery and development of peptide-based medicines, has selected the Benchling R&D Cloud as its central source of truth for scientific data,...

at 03:38
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today an update from a Type C meeting with the FDA, regarding the company's plans for a global...

at 03:35
The Japan Prize Foundation (President: Hiroshi Komiyama) held an award ceremony on Tuesday, April 16 at the Imperial Hotel Tokyo in Tokyo's Chiyoda Ward to confer the Japan Prize on scientists who have made creative and dramatic achievements in the...

at 03:30
AMSilk GmbH ("AMSilk"), a global leader in advanced materials made from spider silk-based proteins, today announces the appointments of Ralph Fraundorfer and Ctibor Kohutovic to its Management Board starting immediately. Ralph Fraundorfer has been...

at 02:54
HanxBio today announced that it has published a research article titled "Narazaciclib, a novel multikinase inhibitor with potent activity against CSF1R, FLT3 and CDK6, shows strong anti-AML activity in defined preclinical models" in the Nature...

at 02:50
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has signed two contracts to provide the radiology module of its enterprise imaging solution with two university medical centers in Germany?Universitätsklinikum Tübingen...



News published on and distributed by: